SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-277335
Filing Date
2021-09-20
Accepted
2021-09-20 16:35:50
Documents
12
Period of Report
2021-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d234071d8k.htm   iXBRL 8-K 26975
  Complete submission text file 0001193125-21-277335.txt   149865

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20210916.xsd EX-101.SCH 2889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20210916_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20210916_pre.xml EX-101.PRE 11403
5 EXTRACTED XBRL INSTANCE DOCUMENT d234071d8k_htm.xml XML 3340
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 211263650
SIC: 2836 Biological Products, (No Diagnostic Substances)